| COVID-19 |
0 |
0.9 |
| Idiopathic Pulmonary Fibrosis |
0 |
0.96 |
| Lung Fibrosis |
0 |
0.87 |
| Lung |
0 |
0.7 |
| Interstitial Lung Disease |
0 |
1 |
| Otolaryngology |
0 |
0.41 |
| CT Scan |
0 |
0.32 |
| Care and Maintenance of Vision |
0 |
0.28 |
| Primary Care |
0 |
0.28 |
| Cough |
0 |
0.23 |
| Dyspnea |
0 |
0.23 |
| Cataract |
0 |
0.19 |
| Asthma |
0 |
0.15 |
| A-Scan Biometry |
0 |
0.14 |
| Scan |
0 |
0.14 |
| Scar |
0 |
0.14 |
| Tissue |
0 |
0.14 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.13 |
| Pneumonia |
0 |
0.13 |
| Sarcoidosis |
0 |
0.13 |
| Social Determinants of Health |
0 |
0.11 |
| Pandemic |
0 |
0.09 |
| Transplantation |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.06 |
| Wound Management |
0 |
0.06 |
| Alabama |
0 |
0.05 |
| Allergy |
0 |
0.05 |
| Arkansas |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Cytokines |
0 |
0.05 |
| Fellowship |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Inhalers |
0 |
0.05 |
| Injury |
0 |
0.05 |
| Medical Literature |
0 |
0.05 |
| Ohio |
0 |
0.05 |
| Plantar |
0 |
0.05 |
| Prognosis |
0 |
0.05 |
| Rural Health |
0 |
0.05 |
| Salary and Compensation |
0 |
0.05 |
| Stress |
0 |
0.05 |
| Thorax |
0 |
0.05 |
| Travel Medicine |
0 |
0.05 |